Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human …

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] As one of the …

Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have …

Oct 6, 2023 · Advances Amgen's Mission to Serve Patients With First-in-Class Rare Disease Medicines. THOUSAND OAKS, Calif., Oct. 6, 2023 /PRNewswire/ -- Amgen (NASDAQ: …

For reimbursement options and information on help paying for Amgen medications in the U.S., please visit amgensupportplus.com for more information.

Amgen's product pipeline will change over time as molecules move through the drug development process, including progressing through clinical phases to licensure and market, returning to …

Jun 14, 2024 · Amgen Inc. manufactures, markets and/or distributes more than 38 drugs in the U.S.

Amgen harnesses the best of biotechnology to fight the world's toughest diseases, and make people's lives easier, fuller and longer. We discover, develop, manufacture and deliver …

Amgen's powerful research and development group uses cutting-edge tools like AI, generative biology and human data to discover and develop new types of medicines to fight the world's …

Amgen advocates for policies in Europe based on sound science that will improve and protect the health of patients with serious illnesses, support advances in clinical development and …